Brief: Tenax Therapeutics Enters Into Amendment To License Agreement Of Co, Orion Corp Dated As Of September 20, 2013
28/01/2022 21:34
Jan 28 (Reuters) - Tenax Therapeutics Inc TENX.O :
* TENAX THERAPEUTICS INC - ON JAN 25, 2022, CO ENTERED INTO
AMENDMENT TO LICENSE AGREEMENT OF CO AND ORION CORPORATION DATED
AS OF SEPTEMBER 20, 2013
* TENAX THERAPEUTICS - AMENDMENT EXTENDS TERM OF AGREEMENT
TO 10
YEARS AFTER LAUNCH OF PRODUCT
* TENAX THERAPEUTICS - ORION MUST NOTIFY CO BEFORE END OF
2024 IF
ORION CHOOSES NOT TO EXERCISE RIGHT TO SUPPLY ORAL PRODUCT TO CO
FOR COMMERCIALIZATION
Further company coverage: TENX.O
((Reuters.Briefs@thomsonreuters.com;))